| NCT ID | NCT06434194 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cagent Vascular LLC |
| Condition | Critical Limb Ischemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-31 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.
Eligibility Criteria
Inclusion Criteria: * Rutherford clinical category 4-6 of the target limb * Age of subjects is \>18 years old * Patients has given informed consent to participate in this study Exclusion Criteria: * De novo or restenotic (without prior stent) stenosis (≥70%) or occlusion * Target lesion is in the BTK arteries, including below the knee popliteal, tibioperoneal trunk, tibial, peroneal, and pedal arteries. * Angiographic visual estimated reference vessel diameter is between 2.0 and 5.0 mm. * Lesion length less than 220 mm
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06434194 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Critical Limb Ischemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06434194 currently recruiting?
Yes, NCT06434194 is actively recruiting participants. Contact the research team at kjclinconsulting@gmail.com for enrollment information.
Where is the NCT06434194 trial being conducted?
This trial is being conducted at New York, United States, New York, United States.
Who is sponsoring the NCT06434194 clinical trial?
NCT06434194 is sponsored by Cagent Vascular LLC. The trial plans to enroll 60 participants.